Test Price
1,900 AED✅ Home Collection Available
Myelin Associated Glycoprotein (MAG) IgM Antibody Test in UAE | 1900 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM.
- Clinical Guidance: Telephonic post-test clinical guidance for result interpretation by a DHA-licensed physician.
- Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The MAG IgM antibody test detects circulating IgM autoantibodies against myelin-associated glycoprotein, a critical biomarker for autoimmune demyelinating peripheral neuropathy and associated monoclonal gammopathy. The analysis is performed using automated enzyme immunoassay (ELISA/EIA) technology, ensuring high specificity and reproducibility.
| Feature | Our Test | Common Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity, ISO 9001:2015 Certified | Variable, may lack DHA benchmarking |
| Method | ELISA/EIA (Automated Enzyme Immunoassay) | Manual ELISA, older generation |
| Turnaround | 2–3 weeks after monthly cut-off | Up to 6 weeks, no local logistics |
| Home Collection | 8 AM – 11 PM, cold-chain VIP phlebotomy | Clinic visit only |
| Insurance Support | Direct billing verification via WhatsApp | Self-pay, no coordination |
Physician Insight & Safety Protocols
Dr. Ajay Singh, General Practitioner (DHA License 36234132), notes: “Elevated MAG IgM antibodies are highly suggestive of chronic demyelinating neuropathy, especially when accompanied by IgM monoclonal gammopathy; yet, nerve conduction studies and clinical context remain essential for a definitive diagnosis. We encourage every patient to share this result with their treating physician for personalized care. Do not alter or discontinue any prescribed medication without direct medical advice.”
Important Advisory
Patients are advised to inform their physician about all current medications and supplements before testing. The MAG IgM antibody test is a diagnostic aid and should be interpreted alongside clinical findings, imaging, and electrophysiological studies.
Safety Exclusion Criteria & Emergency Red Flags
- Active febrile infection or recent immunization may alter antibody levels – reschedule if acutely ill.
- Ongoing high-dose corticosteroid or rituximab therapy can falsely lower results.
- Patients with known IgM paraproteinemia must coordinate with a hematologist before testing.
- ER Red Flags: Sudden severe weakness, difficulty breathing, or acute loss of bladder/bowel control require immediate emergency evaluation.
Patient FAQ & Clinical Guidance
1. What does a positive MAG IgM antibody test indicate?
A positive result indicates IgM autoantibodies attacking myelin-associated glycoprotein, strongly linked to autoimmune demyelinating peripheral neuropathy. It is often associated with monoclonal gammopathy of undetermined significance (MGUS) or lymphoproliferative disorders.
2. How is the blood sample for MAG IgM collected?
A trained phlebotomist collects 2 mL of serum into a serum separator tube under sterile technique. The sample is refrigerated immediately and transported under temperature-controlled cold-chain to our ISO-accredited laboratory.
3. Can I take this test while on immunomodulatory medications?
Yes, but your neurologist must interpret results in light of drugs like corticosteroids or rituximab that may suppress antibody levels. Inform our team of any immunosuppressive therapy at the time of booking.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data and test results are encrypted, stored in ISO 27001-certified systems, and accessible only to authorized medical personnel. Our DHA Facility License No. 1143 ensures continuous oversight by the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | Myelin Associated Glycoprotein (MAG) IgM Antibody |
| Price (AED) | 1,900 |
| Turnaround Time | 2–3 weeks (after monthly cut-off date) |
| Sample Type / Matrix | Serum (2 mL) |
| Methodology Used | ELISA/EIA (Automated Enzyme Immunoassay) |
| ICD-10-CM Code | G61.8 (Other inflammatory polyneuropathies) |
| LOINC Code | 9514-2 (Myelin Associated Glycoprotein IgM Ab [Units/volume] in Serum) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians